Peptídeos
Subcategorias de "Peptídeos"
Foram encontrados 29635 produtos de "Peptídeos"
PEX11A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PEX11A antibody, catalog no. 70R-6611Pureza:Min. 95%RIBC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RIBC1 antibody, catalog no. 70R-4023
Pureza:Min. 95%ZNF550 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF550 antibody, catalog no. 70R-8147
Pureza:Min. 95%SCGN Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SCGN antibody, catalog no. 70R-2887Pureza:Min. 95%KIAA0907 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA0907 antibody, catalog no. 70R-3513Pureza:Min. 95%Annexin A2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANXA2 antibody, catalog no. 70R-1679Pureza:Min. 95%ZFP42 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZFP42 antibody, catalog no. 70R-8451Pureza:Min. 95%CDH23 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CDH23 antibody, catalog no. 70R-6179Pureza:Min. 95%Inhibin Alpha Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of INHA antibody, catalog no. 70R-5692GUCY1B3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GUCY1B3 antibody, catalog no. 70R-5802Pureza:Min. 95%ATP6V1E2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ATP6V1E2 antibody, catalog no. 70R-2360Pureza:Min. 95%GPT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPT antibody, catalog no. 70R-1215
Pureza:Min. 95%KIAA1618 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA1618 antibody, catalog no. 70R-8746Pureza:Min. 95%C9ORF127 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf127 antibody, catalog no. 70R-7003Pureza:Min. 95%PIK3CB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PIK3CB antibody, catalog no. 70R-1633Pureza:Min. 95%TSTA3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TSTA3 antibody, catalog no. 70R-6048Pureza:Min. 95%GTPBP10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GTPBP10 antibody, catalog no. 70R-2076Pureza:Min. 95%DIDO1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DIDO1 antibody, catalog no. 70R-8366
Pureza:Min. 95%AP1G1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AP1G1 antibody, catalog no. 70R-3825Pureza:Min. 95%KCNMA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNMA1 antibody, catalog no. 70R-5152Pureza:Min. 95%DNAJB9 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DNAJB9 antibody, catalog no. 70R-7401Pureza:Min. 95%Carbonic Anhydrase Vb Blocking Peptide (Mitochondrial)
A synthetic peptide for use as a blocking control in assays to test for specificity of CA5B antibody, catalog no. 70R-4459
Pureza:Min. 95%PIM1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PIM1 antibody, catalog no. 70R-2105Pureza:Min. 95%CYP2A7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2A7 antibody, catalog no. 70R-7502Pureza:Min. 95%TBC1D10C Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TBC1D10C antibody, catalog no. 70R-3614Pureza:Min. 95%KCNA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNA1 antibody, catalog no. 70R-5148Pureza:Min. 95%CLECL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLECL1 antibody, catalog no. 70R-2329Pureza:Min. 95%HADHB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HADHB antibody, catalog no. 70R-2497Pureza:Min. 95%ANPEP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANPEP antibody, catalog no. 70R-10232Pureza:Min. 95%GABRE Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GABRE antibody, catalog no. 70R-5221Pureza:Min. 95%ORAI1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ORAI1 antibody, catalog no. 70R-6459Pureza:Min. 95%GLE1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GLE1 antibody, catalog no. 70R-2303Pureza:Min. 95%POLR2B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of POLR2B antibody, catalog no. 20R-1076Pureza:Min. 95%PGK1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PGK1 antibody, catalog no. 70R-1199Pureza:Min. 95%Rab23 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Rab23 antibody, catalog no. 70R-9451Pureza:Min. 95%SIX1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SIX1 antibody, catalog no. 70R-8276Pureza:Min. 95%TRIM54 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TRIM54 antibody, catalog no. 70R-2647Pureza:Min. 95%DBX1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DBX1 antibody, catalog no. 70R-8891Pureza:Min. 95%MAGEA11 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA11 antibody, catalog no. 70R-9920Pureza:Min. 95%ZNF259 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF259 antibody, catalog no. 70R-8256
Pureza:Min. 95%C16ORF65 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C16orf65 antibody, catalog no. 70R-4265
Pureza:Min. 95%C22orf31 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C22orf31 antibody, catalog no. 70R-9572Pureza:Min. 95%KCTD19 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCTD19 antibody, catalog no. 70R-5057Pureza:Min. 95%CLEC4M Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLEC4M antibody, catalog no. 70R-8545Pureza:Min. 95%H-QDVH-OH
Please enquire for more information about H-QDVH-OH including the price, delivery time and more detailed product information at the technical inquiry form on this pageH-2kb tetramer peptide - G4
Please enquire for more information about H-2kb tetramer peptide - G4 including the price, delivery time and more detailed product information at the technical inquiry form on this pageMuscarinic Toxin 3
A synthetic snake venom peptide, sourced from the Green Mamba, Dendroaspis angusticeps. It can be applied as a specific ligand for Muscarinic Acetylcholine Receptor-4 (M4) and this product is available as a 0.1mg vial with disulfide bonds between Cys3- Cys24, Cys17- Cys42, Cys46- Cys57, and Cys58- Cys63.Fórmula:C319H489N89O97S8Pureza:Min. 95%Peso molecular:7,379.4 g/mol[D-Leu7]-(-)-Ternatin
Ternatin is a type of molecule known as a natural product or secondary metabolite and can be used as a fat accumulation inhibitor against 3T3-L1 adipocytes. Specifically, it is a cyclic peptide isolated from marine sources. Ternatins have been studied for their potential biological activities, including their anticancer properties. These molecules belong to the broader category of natural products, which are compounds derived from living organisms and often possess interesting biological activities that make them of interest for various applications in medicine, agriculture, and other fields.This product comes as a 1mg vial.Pureza:Min. 95%LGALS1 Human
LGALS1 is a cytokine that is secreted by macrophages in response to LPS, IL-1 and TNF. This cytokine has been shown to promote the secretion of inflammatory cytokines, such as IL-6, IL-8 and TNF-α. LGALS1 is also involved in the recruitment of neutrophils and monocytes to sites of inflammation. LGALS1 has been shown to be involved in regulating the expression of proteins that are involved in cell signaling pathways, including NF-κB and MAPK.Pureza:Min. 95%Schizophrenia Related Peptide
Schizophrenia Related Peptide is a research tool that can be used to study ion channels and receptors. It is an artificial peptide that has the same amino acid sequence as the part of the human brain that is believed to be responsible for schizophrenia. The Schizophrenia Related Peptide can bind to cell membranes and inhibit protein interactions, which may lead to new pharmacological treatments for schizophrenia.
Fórmula:C15H29N3O5Pureza:Min. 95%Peso molecular:331.41 g/molLaminin Pentapeptide YIGSR-NH2
CAS:Laminin is a structural protein that provides a scaffold for cell-cell and cell-matrix interactions. Laminin Pentapeptide YIGSR-NH2 is a synthetic peptide that has been shown to be an activator of the laminin receptor and an inhibitor of ion channels. It has also been used as a research tool in studies on antibody production, life science, cell biology, and pharmacology. This peptide is highly pure with no detectable contaminants.Fórmula:C26H43N9O7•2CH3COOH•2H2OPureza:Min. 95%Peso molecular:749.81 g/molProrenin (314-337), human
Prorenin is a peptide that is a member of the renin-angiotensin system. It is an activator of angiotensin converting enzyme that converts angiotensin I to angiotensin II, which has potent cardiovascular effects. Prorenin (314-337) is purified from human plasma by ion exchange chromatography and has a purity >98%. It can be used as a research tool or as an antibody for immunohistochemical staining. Prorenin (314-337) has been shown to inhibit the activity of several ion channels, including Ca2+ channels, Na+ channels, and K+ channels in rat brain cells.Pureza:Min. 95%KD20 peptide
KD20 peptide is a lysine-aspartic acid peptide with 20 repeating units. KD20 peptide is used to stimulate CD4+ T cells in vitro and KD20 actions result in protection against abscesses induced by bacteria.
SARS-CoV-2 Spike RBD 348-357 peptide
SARS-CoV-2 Spike RBD 348-357 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). SARS-CoV-2 Spike RBD 348-357 peptide is useful for vaccine development and for structure-activity relationship studies SARS-CoV-2 Spike (S) glycoprotein Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells. With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane. SARS-CoV-2 Spike RBD: The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry. SB-PEPTIDE also offers SARS-CoV-2 Spike RBD 348-357 (Biotin-LC) peptideSARS-CoV-2 Spike RBD 513-520 peptide
SARS-CoV-2 Spike RBD 513-520 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). SARS-CoV-2 Spike RBD 513-520 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.
SB-PEPTIDE also offers SARS-CoV-2 Spike RBD 513-520 (Biotin-LC) peptideSARS-CoV-2 Spike RBD 395-430 peptide
SARS-CoV-2 Spike RBD 395-430 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). SARS-CoV-2 Spike RBD 395-430 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.
SB-PEPTIDE also offers SARS-CoV-2 Spike RBD 395-430 (Biotin-LC) peptideSARS-CoV-2 Spike RBD 319-335 peptide
SARS-CoV-2 Spike RBD 319-335 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Domain (RBD). SARS-CoV-2 Spike RBD 319-335 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBD:
The receptor-binding domain in SARS-CoV-2 Spike protein allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.
SB-PEPTIDE also offers SARS-CoV-2 Spike RBD 319-335 (Biotin-LC) peptideTetanus Toxin (830-844) peptide - QYIKANSKFIGITEL
TET 830/Tetanus Toxin (830-844) peptide – QYIKANSKFIGITEL
TAT (47-57) peptide
AT (47-57) peptide, also known as HIV-1 TAT protein, is the most characterized fragment of the HIV transactivator protein (TAT). TAT (47-57) peptide was show to be a cell-penetrating peptide (CPP). TAT (47-57) is an arginine-rich peptide which directly penetrates plasma membrane and stabilized DNA. TAT (47-57) has the ability to translocate the plasma membrane and facilitate the delivery of various cargoes such as protein, peptide, antibodies, and liposomes. It represents an important tool to increase the biodistribution of drugs.ovalbumine 154-159
Ovalbumin 154-159, also nammed TNGIIR peptide, is a portion of interest of the egg white albumen.
ω-Hexatoxin-Hv1a
Blocker of mid-low- (M-LVA) and high-voltage-activated (HVA) insect calcium channel (Ca(v)) currents
RANTES
RANTES (or Regulated upon Activation, Normal T-cell Expressed and Secreted), also known as CCL5 (Chemokine (CC chemokine ligand 5), is a protein classified as a chemotactic cytokine or chemokine.
Chemokines are small soluble proteins that act as molecular signals to induce cellular migration during inflammation.
RANTES is a member of the CC chemokine family and is involved in immunoregulatory and inflammatory processes.
RANTES is expressed in a lot of immune cells and acts as a potent chemoattractant for T-cells, basophils, eosinophils, monocytes and other cell types by playing a major role in recruiting leukocytes into inflammatory sites and to activate them. RANTES also induces proliferation and activation of certain natural killer cells.
RANTES synthesis is induced by TNF-alpha and IL-1 alpha, interacts with CCR3, CCR1 and CCR5 and activates some G-protein coupled receptors.
Many of the biological activities of RANTES (Ca2+ influx, chemotactic response, basophil activation, T-cell signaling) are observed between 40 and 8000 ng/mL.ACE2 biotinylated peptide library
Angiotensin-converting enzyme 2 (ACE2) is an enzyme involved in the cardiovascular system by decreasing arterial pressure by catalyzing the conversion of angiotensin II to angiotensin (1-7). Angiotensin II is a vasoconstrictor and angiotensin (1-7) is a vasodilatator. This effect makes ACE2 a therapeutic target for cardiovascular disease.SARS-CoV-2 Spike RBM 500-509 peptide
SARS-CoV-2 Spike RBM 500-509 peptide is an epitope of interest of the SARS-CoV-2 Spike S glycoprotein Receptor-Binding Motif (RBM). SARS-CoV-2 Spike RBM 500-509 peptide is useful for vaccine development and for structure-activity relationship studies
SARS-CoV-2 Spike (S) glycoprotein
Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.
With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane.
SARS-CoV-2 Spike RBM:
The receptor-binding domain in SARS-CoV-2 Spike protein contains a receptor-binding motif RBM. SARS-CoV-2 Spike RBM is the main functional motif in RBD and allows contacts between the S protein and the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.
SB-PEPTIDE also offers SARS-CoV-2 Spike RBM 500-509 (Biotin-LC) peptideMBP (85-99)
MBP (85-99) peptide competes with Myelin Basic Protein, it inhibits its binding to HLA-DR2 and IL-2. MBP (85-99) peptide is able to suppress experimental autoimmune encephalomyelitis (EAE).Heavy calcitonin peptide
Heavy calcitonin peptide – Stable Isotope PeptideHuman Calcitonin (hCT) is a 32-amino acid hormone peptide belonging to the Calcitonin/Calcitonin-gene related peptide (CGRP) family, that also comprises amylin, adrenomedullin (AM) and adrenomedullin2/intermedin (AM2/IMD). Calcitonin is characterized by a N-terminal disulfide bond that forms a 7 amino acid ring structure, a region with a α-helix tendency and an amidated C-terminus1.Calcitonin peptide is produced by C cells of the thyroid gland and binds preferentially to the G-protein coupled receptor, calcitonin receptor (CTR)1. Calcitonin receptor signals through activated Gs protein and the production of cAMP second messenger molecules by adenylyl cyclase1. The dissociation constant (Kd) of calcitonin receptors expressed by a human ovarian small cell carcinoma line is approximately 4.6 nM for human Calcitonin2.Calcitonin is involved in the homeostasis of calcium and phosphorus, and the regulation of bone dynamics. At the basal state, calcitonin secretion reduces plasma calcium and phosphorus levels, and promote bone formation. In Calca -/- mice, a murin particle-induced osteolysis model, Calcitonin peptide has been used as a test compound for studying the effects of calcitonin deficiency. It has been shown that artificial calcitonin subsitution inhibits bone resorption by reducing the formation of osteoclasts and thereby the resulting osteolytic reaction3. The Hypocalcemic Human calcitonin was also used as a positive control to monitor changes in serum calcium levels in HHD transgenic mice vaccinated with Parathyroid hormone-related protein (PTH-rP)-derived peptides in the context of anti-cancer immunotherapy study4. Moreover, it has been reported that calcitonin peptide is a potent stimulator of uncapacitated mouse spermatozoa by regulating a specific isoform of adenylyl cyclase and the production of cAMP, which plays a pivotal role in mammalian sperm function5.sb-PEPTIDE provides stable isotope labeled calcitonin peptide. This peptide has been quantified accurately using amino acid analysis.Biotin-FluM1 (58-66)
Biotin-FluM1 (58-66) is the N-ter biotinylated version of FluM1 (58-66). Biotin-FluM1 (58-66) can be used in the analysis of antigen-specific T cells. FluM1 (58-66): FluM1 (58-66) is a short part of the matrix protein of Influenza A virus which is the most abundant component of this enveloped virus localized under the viral lipid envelope. The GILGFVFTL epitope is highly conserved in Influenza A virus strains at a rate of 93% for 69 strains tested. Human Influenza epitopes may bind MHC molecules and then may be recognized by CD8+ cytotoxic T cells. Applications of FluM1 (58-66): FluM1 (58-66) is used to stimulate CTL responses in peripheral blood mononuclear cells (PBMCs). Then, ELISPOT assay is used to quantify peptide epitope specificity and IFN-γ releasing effector cells. FluM1 (58-66) has shown CTL responses qualified of immunodominant with restriction by HLA-A*02:01. It has also been detected CTL responses when FluM1 (58-66) is restricted by all HLA-C. Therefore, FluM1 (58-66) may help to understand the reaction of immune system against Influenza virus of each populations having different HLA type. FluM1 (58-66) has indeed prompted research to develop T-cell vaccine strategies capable of inducing specific CTL responses in patients upon immunization with Influenza M1 antigenic epitope. MVA-NP+M1 vaccine use GILGFVFTL epitope and is tested in clinical trial. Potential cross-reactivity with HIV-1 p17 Gag (77-85): Moreover, FluM1 (58-66) share similarities with HIV-1 p17 Gag (77-85) which can potentially show a cross-reactivity between these epitopes. It has been demonstrated a cross-reactivity and results suggest that immunity following infection by Influenza virus causes specific immune response to HIV-1 p17 Gag (77-85). Sequence: Biotin-GILGFVFTLScrambled Cathelicidin antimicrobial peptide 18
Scrambled LL-37 has the same peptide sequence as LL-37 but loses helixforming property.
Scrambled LL-37 can be used as a negative control of LL-37 studies.Melan-A (26-35) scrambled
SB-peptide offers the scrambled version of Melan-A/MART-1 (26-35). AIEIAGGLTV can be used as a negative control of Melan-A/MART-1 (26-35) studies. SB-peptide offers also Melan-A/MART-1 (26-35) (see section Melan-A/MART-1 (26-35)). Native Melan-A (26-35) decapepetide derives from the melanocyte lineage-specific protein Melan-A/MART-1, which is expressed in almost 75-100% of primary and metastatic melanomas1.KLPGF
KLPGF peptide is a sequence from egg white albumen. This peptide have recently shown interest for Alzheimer’s disease.
MiniAp-4 peptide
MiniAP-4 peptide is a short nontoxic derivative of apamin (a neurotoxin from bee venom) used as a blood-brain barrier (BBB) shuttle peptide.
GsMTx4
CAS:GsMTx4 is a ryanodine receptor agonist that binds to the ryanodine receptor and activates signal pathways. It has been shown to activate mechanosensitive channels and regulate intracellular Ca2+ levels by inducing an increase in Ca2+ release from the endoplasmic reticulum. GsMTx4 has also been shown to have pharmacological effects on cells, as well as physiological effects on Grammostola spatulata, such as inhibition of locomotion and increased mortality. GsMTx4 has also been shown to have antiviral properties against infectious diseases such as influenza, herpes simplex virus-1, and West Nile virus.Fórmula:C185H273N49O45S6Pureza:Min. 95%Peso molecular:4,101.89 g/molAPETx2
CAS:APETx2 is a drug that inhibits the activity of apetx2, a protein which is involved in the regulation of ion channels and endothelin-A receptors. APETx2 has been shown to inhibit the activity of channels involved in pain perception and may have therapeutic potential as a pressor agent. This drug has also been shown to have anti-inflammatory properties, which are likely due to its inhibition of EGF receptor activity. The mechanism of action for this drug remains unclear, but it may work by blocking the channel or receptor for EGF.
Fórmula:C196H280N54O61S6Pureza:Min. 95%Peso molecular:4,561 g/molIL 3 Mouse
IL 3 Mouse is a recombinant form of human IL-3 protein with a molecular weight of approximately 30,000 Daltons. IL-3 is an important cytokine in the immune system. It has been shown to play a role in the differentiation and proliferation of T-cells and B-cells. This antibody was generated by immunizing rabbits with purified rat IL-3 protein. The antibody binds to both mouse and human IL-3 proteins with high affinity and specificity.Pureza:Min. 95%Z-Phe-Tyr
CAS:Z-Phe-Tyr is a potent irreversible inhibitor of serine proteases. It binds to the active site of the enzyme and prevents it from performing its function, which is to cleave proteins at specific sites. Z-Phe-Tyr has been shown to be effective against inflammatory bowel disease, but not against other types of diseases such as diabetes mellitus or rheumatoid arthritis. The drug inhibits protease activity and can be used in experimental models to study the molecular mechanisms of inflammation and inflammatory diseases.Fórmula:C26H26N2O6Pureza:Min. 95%Peso molecular:462.49 g/molL-Asparaginase
L-asparaginase is a drug that inhibits the production of asparagine, which is an amino acid that is used in the synthesis of proteins. It has been shown to be effective against T-cell lymphomas, as well as other cancers such as leukemia and colorectal cancer. L-Asparaginase has been shown to inhibit mitochondrial functions in blood samples from patients with prostate cancer. This inhibition may lead to cell death. L-Asparaginase binds to the sephadex G-100 column in a similar manner to sodium citrate and prevents the formation of polymers when it combines with ATP. The enzyme can also be found in primary cells and liver cells, where it causes hypoglycemia by inhibiting glucose production. L-Asparaginase also inhibits dna synthesis by binding to DNA polymerases, preventing their attachment to nucleotide triphosphates (e.g., ATP).
Pureza:Min. 95%Guanylate Kinase 1, human, recombinant
Guanylate kinase 1 is a member of the guanylate kinase family. It is a protein that in humans encoded by the GMNK1 gene. Guanylate kinases catalyze the reversible transfer of phosphate groups from ATP to guanosine diphosphate (GDP). They are involved in regulating the balance between GTP and GDP in cells, which has been shown to be important for many cellular processes, including cell signaling, cytoskeletal remodeling and apoptosis. Guanylate kinase 1 is an inhibitor of receptor tyrosine kinases, with an IC50 value of 2 μM. It also has been shown to be able to activate L-type calcium channels at concentrations greater than 100 μM. The recombinant human guanylate kinase 1 used in this study was expressed in E. coli and purified using affinity chromatography.Pureza:Min. 95%Adrenomedullin 2 (Rat)
Adrenomedullin 2, a peptide hormone product, of rat source and has disulfide bond between Cys10-Cys15. Adrenomedullin 2 can be applied as a potent cardiovascular and renal regulator as well as a suppressor for food intake and gastric emptying. This product is available as a 0.1mg vial.Fórmula:C226H361N75O64S2Pureza:Min. 95%Peso molecular:5,216.9 g/molAnti PACAP38 (22-38)(Human) Serum
Anti PACAP38 (22-38)(Human) Serum is a research tool for the study of Protein Activator of cAMP Catalytic Subunit Protein 38. It is an activator that binds to the receptor and has been shown to activate cell signaling pathways. This antibody can be used to detect PACAP38 in human serum.Pureza:Min. 95%Bis-dPEG®3-NHS Ester
CAS:Bis-dPEG®3-NHS Ester is a PEG polymer categorised as homobifunctional PEG (X-PEG X). Used as a linker, bis-dPEG®3-NHS Ester is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.
Fórmula:C53H71F4NO15Pureza:Min. 95%Peso molecular:1,038.14 g/molGroEL (HSP60) E.coli (recombinant)
GroEL is a protein that is found in bacteria. It is an ATPase and a chaperone, which helps other proteins maintain their correct shape. GroEL can be purified from E. coli or from the bacterium Bacillus stearothermophilus. The recombinant form of GroEL consists of the protein and its co-factor, dithiothreitol (DTT). This protein has been shown to have ion channel activity, which may play a role in cell excitability as well as receptor-ligand interactions. It also binds to peptides and has been used as a research tool for pharmacology, protein interactions, and cell biology studies. GroEL has been shown to activate certain enzymes such as proteases, kinases, phosphatases, and ribonucleotide reductase. It also inhibits other enzymes such as lipases and esterases.Pureza:Min. 95%CRF (Human, Rat, Mouse)-HS ELISA Kit (1ea)
CRF (Human, Rat, Mouse)-HS ELISA Kit is a sandwich ELISA that can be used to detect the human CRF-HS protein in human serum or plasma.Pureza:Min. 95%Dipeptidyl-Peptidase IV, human, recombinant
Dipeptidyl-peptidase IV (DPP4) is a complex enzyme that is expressed in the pancreas and regulates glucose-dependent insulinotropic polypeptides. DPP4 cleaves the amino terminal dipeptide from these polypeptides, which prevents the activation of pancreatic β-cells. The recombinant human form of this enzyme has been shown to activate T cells and induce apoptosis in insect cells. Its activity against chemokines in vitro may be due to its ability to cleave glycosylated polypeptides. This enzyme also has anti-inflammatory effects by inhibiting the production of proinflammatory cytokines such as tumor necrosis factor α (TNFα), interleukin 1β (IL1β), and IL6.
Pureza:Min. 95%Cystatin C Heavy Tryptic Peptide Standard (4nmol)
Cystatin C Heavy Tryptic Peptide Standard for use in protein identification and quantitation studies. Cystatin C is a non-glycosylated, basic protein which can be used as a biomarker to determine kidney function.Pureza:Min. 95%Thymosin-b4 Human Recombinant
Please enquire for more information about Thymosin-b4 Human Recombinant including the price, delivery time and more detailed product information at the technical inquiry form on this pagePureza:Min. 95%Amyloid β-Protein (Human, 1-16)
CAS:Amyloid beta-protein (Aβ) is a peptide that is associated with Alzheimer's disease. It is a research tool for understanding the biology of Aβ. The Aβ peptide has been shown to activate a number of receptors and ion channels, including the nicotinic acetylcholine receptor, which may be due to its ability to bind to these proteins with high affinity. Amyloid beta-protein has also been shown to bind antibodies, which may be due to its ability to act as an antigen. Amyloid beta-protein inhibits the function of ion channels and can be used in pharmacological studies as a tool for understanding how this protein interacts with other proteins.Fórmula:C84H119N27O28Pureza:Min. 95%Peso molecular:1,955 g/mol
![[D-Leu7]-(-)-Ternatin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FTNN-4464-V.webp&w=3840&q=75)
